Gateley Holdings Plc Q&A with CEO Michael Ward (LON:GTLY)
11 December 2017
Investors with an eye on the biotechnology sector might find Cartesian Therapeutics, Inc. (RNAC) a compelling candidate, especially given its remarkable potential upside of 455.80%. As a clinical-stage biotechnology company,..
Mereo BioPharma Group plc (NASDAQ: MREO) is a London-based biopharmaceutical company making waves in the biotechnology sector. With a market capitalization of $62.87 million, Mereo BioPharma is focused on the..
Anbio Biotechnology (NNNN), a promising player in the healthcare sector, operates within the medical instruments and supplies industry. Headquartered in Frankfurt am Main, Germany, this biotech company has carved out..
Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands out in the biotechnology landscape with a focus on developing targeted therapies for life-threatening diseases. Despite a robust market cap of $6.96 billion, the..
ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a dynamic player within the technology sector, specifically in the software application industry. With a focus on providing go-to-market intelligence and engagement platforms,..
DocuSign, Inc. (NASDAQ: DOCU), a leader in electronic signature solutions, continues to capture attention in the technology sector with its innovative products and substantial potential upside. The company’s current stock..
TotalEnergies SE (TTE), a French energy giant with a market cap of $166.48 billion, is making waves in the oil and gas integrated industry. As a multi-energy company, TotalEnergies produces..
Gossamer Bio, Inc. (NASDAQ: GOSS), a San Diego-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at addressing pulmonary arterial hypertension (PAH). With..
AMTD Digital Inc. (HKD), a relatively new player in the technology sector, has been capturing attention with its astounding revenue growth of 1,085.90%. Despite this impressive figure, investors might find..
Immutep Limited (NASDAQ: IMMP), an innovative player in the biotechnology sector, is capturing the attention of investors with its ambitious focus on developing immunotherapies for cancer and autoimmune diseases. The..
Investors eyeing the healthcare sector might find Senseonics Holdings, Inc. (NYSE: SENS) an intriguing prospect, particularly with its impressive projected upside of 145.67%. Specializing in continuous glucose monitoring (CGM) systems,..
Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making significant strides in the precision oncology sector, focusing on therapies for RAS/MAPK pathway-driven cancers. With a market capitalization of $3.58..
SANUWAVE Health, Inc. (NASDAQ: SNWV), a promising player in the healthcare sector, particularly in the medical devices industry, is capturing the attention of investors with its innovative approach to regenerative..
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline in gastrointestinal therapeutics and an impressive potential upside..
Absci Corporation (NASDAQ: ABSI) stands at the cutting edge of biotechnology, leveraging artificial intelligence to innovate in drug creation. Operating in the burgeoning healthcare sector, Absci is carving out a..
Nano-X Imaging Ltd (NASDAQ: NNOX), a company at the intersection of healthcare and technology, has been gaining attention for its innovative approach in the medical devices sector. Headquartered in Petah..
Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector due to its promising pipeline of gene and cell therapies and a compelling potential..
Alumis Inc. (NASDAQ: ALMS), a burgeoning force in the biotechnology sector, is drawing significant attention from investors with its promising pipeline of treatments for autoimmune disorders. As a clinical-stage biopharmaceutical..
Investors with an eye on the biotechnology sector might find Entrada Therapeutics, Inc. (NASDAQ: TRDA) an intriguing prospect, with a potential upside of 67.12% based on current analyst ratings. This..
Investors eyeing opportunities in the healthcare sector may want to take a closer look at Zhengye Biotechnology Holding L (ZYBT), a Chinese company focused on the development and sale of..
